General Medicine
General Medicine Raises $120M Series B for Nationwide Healthcare Store
General Medicine announced $120M in Series B financing on October 6, 2026. General Medicine raised a $120 million Series B led by Andreessen Horowitz to expand its nationwide healthcare store into more categories of care.
Round details
The financing includes backing from Andreessen Horowitz, Matrix, VXI Capital, Eli Lilly and Company, Mercy Health (through Granger Management), BoxGroup. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $120M
- Total funding reported: $152M
- Headquarters: San Francisco, CA
How the company plans to use the capital
General Medicine said it will use the new funding to expand its store into more categories of care. The announcement did not specify a more detailed use of proceeds.
Why this matters for GTM teams
The round brings General Medicine’s total funding to $152 million. Its store lists more than 2,900 products and services across medications, labs, telehealth, specialist e-consults and select in-person visits, and shows insurance and cash prices before customers decide.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: General Medicine Series B announcement.
Company Info
Investors (6)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


